05.11.2014 Views

annual Report 2009 - STRATEC Biomedical AG

annual Report 2009 - STRATEC Biomedical AG

annual Report 2009 - STRATEC Biomedical AG

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

10:38 11:40<br />

8.38 a.m.<br />

Talking to the<br />

doctor and giving<br />

blood<br />

Once the doctor has explained the<br />

background to the test, the blood sample<br />

is taken. This generally involves several<br />

milliliters of blood being taken in a test<br />

tube labeled with the patient’s name and<br />

a barcode enabling the sample to be<br />

clearly allocated.<br />

Depending on the type of test to be<br />

performed, a variety of analytical techniques<br />

and applications are used. One<br />

area that is still quite new is molecular<br />

diagnostics. This enables the genetic<br />

makeup of the individual pathogens<br />

present in the blood to be investigated.<br />

This way, more precise results can be<br />

obtained considerably faster. Invitek,<br />

a company acquired by <strong>STRATEC</strong> in<br />

April <strong>2009</strong>, specializes in molecular biological<br />

applications and has developed<br />

reagent systems enabling DNS and RNS<br />

to be separated from cell components not<br />

required for the analysis. Together with<br />

<strong>STRATEC</strong>, Invitek has further optimized<br />

the automation of this so-called purification<br />

process. As a result, <strong>STRATEC</strong> can<br />

now offer its customers and partners an<br />

additional, important component in its<br />

capacity as an OEM supplier of complete<br />

molecular diagnostic system solutions.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!